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Abstract
The benefits of exercise for aging have received considerable attention in both the popular and
academic press. The putative benefits of exercise for maximizing cognitive function and
supporting brain health have great potential for combating Alzheimer’s disease (AD). Aerobic
exercise offers a low-cost, low-risk intervention that is widely available and may have disease
modifying effects. Demonstrating aerobic exercise alters the AD process would have enormous
public health implications. The purpose of this paper is to a report the protocol of a current,
community-based pilot study of aerobic exercise for AD to guide future investigation. This
manuscript provides 1) an overview of possible benefits of exercise in those with dementia, 2) a
rationale and recommendations for implementation of a community-based approach, 3)
recommendation for implementation of similar study protocols, 4) unique challenges in
conducting an exercise trial in AD.
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Introduction
Americans are living longer than ever before. Six percent of the population is 75 years or
older and this age group is expected to increase by 80% in the next decade. [1, 2] Aging
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brings an increased incidence of cognitive and physical decline, especially in those in the
eighth decade and beyond.[3] One in 8 individuals over 65 is now living with Alzheimer’s
disease (AD),[4] and the annual treatment costs of AD are estimated at $183 billion in the
US. Spending on dementia care is expected to increase 600% over the next 40 years.[4]
Delaying the onset or slowing the progression of AD would significantly reduce annual
health care costs in the US.[5] However, there are currently no established and accepted
disease modifying or preventive treatments for AD.
A wealth of animal research data suggests that exercise positively impacts brain health.
Increased physical activity may have a trophic effect on the brain, particularly the
hippocampus. For instance, exercise increases brain-derived neurotrophic factor (BDNF) [6]
and other important neurochemicals [7] supporting brain growth and survival. Exercise
appears to stimulate neurogenesis,[8] enhance neuronal survival,[9] increase resistance to
brain insults [10, 11] and increase synaptic plasticity.[12] Exercise promotes brain
vascularization,[13, 14] mobilizes gene expression profiles predicted to benefit brain
plasticity,[15] and maintains cognitive function.[16] Additionally, exercise effects on the
brain may reduce vascular risk factors (heart disease,[17] atherosclerosis,[18] stroke,[19]
and diabetes [20–24]) that are believed to place an individual at risk for dementia, vascular
dementia, and AD.[25]
Further, there is limited but compelling animal data suggesting that exercise may have
disease-modifying benefits in AD. For instance, increased physical activity in mouse models
of AD reduces neuropathological burden [26] and may promote hippocampal neurogenesis.
[27] The reduction of β-amyloid in the exercising mice was evident in both cortical and
hippocampal regions of the brain suggesting that voluntary exercise may mediate the
amyloid cascade in favor of reduced production of β-amyloid.[26] Despite the evidence that
aerobic exercise may be disease modifying in animals, there is a paucity of rigorous trials of
aerobic exercise effects on cognitive function in the earliest stages of AD in humans.[28]
The lack of well-designed, randomized controlled trials (RCT) that have investigated
exercise effects on cognition has led to scientific position statements [29] and prominent
public media editorials [30] on the insufficiency of evidence for addressing cognitive
decline. Studies of exercise in dementia are significantly limited by poorly-defined samples
and insufficient outcome measures and exercise regimens. Many of these studies include
poorly characterized participants or use insensitive cognitive and physical outcome
measures. For example, one meta-analysis of older studies suggested physical exercise can
benefit physical and cognitive performance [31] but the results are derived from a mix of
exercise modalities and dementia states.[32–53] Often these mixed studies include
institutionalized elderly patients in nursing homes or psychiatric hospitals with poorly
characterized cognitive impairment. Few focus on diagnosing AD [40, 54] and fewer
examine individuals with early stage AD.[55] Exercise interventions are variable and
usually involve resistance (sit-to-stand exercises, strength training, isometric exercises in
sitting positions)[41, 42, 45, 47, 56, 57] and endurance training.[53, 58, 59] Outcome
variables vary widely and include mobility and balance, strength, reaction time, and
functional measures.[31] Endurance measures are generally the distance walked over a set
time (i.e., modified 6-minute walk). To our knowledge, few studies include standard
measures of exercise adaptation such as insulin sensitivity, body composition, lipids, and
VO2 peak in people with well-characterized early stage dementia.
There is promising evidence that aerobic exercise benefits brain health and cognitive
function in AD. Cross-sectional evidence from our center has found that peak oxygen
consumption (VO2 peak, a consensually valid measure of aerobic fitness and standard
outcome measure of aerobic exercise interventions) in early stage AD is associated with
whole brain volume measures, with higher VO2 peak associated with less brain atrophy and
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slower dementia progression.[60–62] In one recent randomized controlled trial (RCT) for
individuals with MCI, aerobic exercise improved executive cognitive function, especially in
women.[55] Importantly, this study demonstrated that a similar, community-based approach
was feasible and has the potential to modify cognitive measures. Exercise may also improve
mood and functional capacity.[40] Ongoing RCTs of home-based programs will shed further
light on the role of exercise for managing AD, but there is a need for more research among
community-dwelling adults in the earliest stages of AD.
While it is common for clinicians to recommend a physically active lifestyle to those with
AD, the benefits of exercise in AD are not well-defined and evidence to develop guidelines
for the prescription of exercise in AD is lacking.[29, 63] Though physical activity typically
declines with cognitive impairment,[64] a meta-analysis demonstrated physical activity
interventions to be successful for improving physical and functional performance as well as
cognition.[31] suggesting that improving exercise habits is feasible for this population.
Although there is consensus that current recommendations (~ 30 minutes of exercise most
days of the week) provide general health benefits to older adults,[65] there remains a need
for well-designed RCTs to test the long-term benefits of exercise for preventing cognitive
and functional decline. Rigorous RCTs are challenging for a number reasons including but
not limited to their expense, need for control interventions, and recruitment of a cohort of
sufficient size. These challenges are magnified by the unique needs of those with AD and
their caregivers.
Aerobic exercise offers a low-cost, low-risk intervention that is widely-available and may
have disease modifying effects. Demonstrating aerobic exercise alters the AD process would
have enormous public health implications. The protocol outlined in this report builds on the
strengths from prior programs [40, 55] and capitalizes on existing and well recognized
community resources. Additionally, it uses publically endorsed exercise recommendations,
while providing information on cognitive, functional and physiologic measures that may be
sensitive to aerobic exercise training in individuals in the earliest stages of AD.
Methods
The University of Kansas Alzheimer’s Disease Center (KU ADC) is currently supporting a
trial of aerobic exercise for cognition; the Alzheimer’s Disease Exercise Program Trial
(ADEPT) for adults over 55 in the earliest stages of AD. Personalized aerobic exercise
programs are carried out at the Young Men’s Christian Association of Greater Kansas City
(the Y) locations.
Study Design and Specific Aims
ADEPT is a 26 week RCT of aerobic exercise vs. non-aerobic activities in individuals 55
years of age and older in the earliest stages of AD. Participants are randomized to a control
arm (non-aerobic activities) or treatment arm of 150 minutes per week of aerobic exercise,
typically treadmill walking. All measures are assessed at baseline. Cognitive testing is
repeated at Week 13 and all measures are repeated after Week 26.
This study is designed to generate efficacy data to inform a larger multi-site trial on our
theories regarding the potential positive benefits of aerobic fitness with respect to cognition
(Aim 1), and physical functioning and mental well being (Aim 2). It also seeks to explore
potential disease-modifying benefits and potential mechanisms relating aerobic fitness with
brain health. Aim 1 uses co-primary outcome measures of memory and executive function
data over 26 weeks in subjects participating in aerobic exercise vs. non aerobic activities in
individuals in the earliest clinical stages of MCI and AD. Aim 2 uses co-primary outcomes
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include the Disability Assessment in Dementia (daily function) and the Cornell Depression
Scale (behavior) to quantify physical functioning and mental well being.
Two exploratory aims are designed (Aim 3) to refine neuroimaging biomarker measures to
assess potential disease-modifying effects of exercise (global and hippocampal brain volume
change over 26 weeks) and (Aim 4) to examine potential underlying systemic mechanisms
relating fitness with brain health (insulin, insulin-like growth factor c-reactive protein,
interleukin-6, and TNF-alpha).
Subject Recruitment
The KU ADC has established an infrastructure for the identification, recruitment, and
characterization of older adults both with and without dementia. Beginning in 2004, we
developed a registry of individuals who have consented to be contacted regarding research
studies. Other institutional databases of older adult research participants supplement our
contact list of potential enrollees through mailings. In addition, the KU ADC and the Y have
jointly designed a recruitment and marketing plan. Marketing materials (flyers, posters,
postcards) are distributed at the Y and community locations, based on the population of
older adults. KU ADC staff distributes study information in health fairs across the Kansas
City community, conducting memory and physical function screens to emphasize the
importance of physical activity and wellness. Often these are joint appearances with KU
ADC and the Y staff to highlight the partnership in the community. Study staff also meets
with medical residents and physicians to share information about the study. Family
physicians, cardiologists, and neurologists are given pocket-sized laminated cards with basic
study qualifications. These physicians are encouraged to share program information with
qualified participants.
To date, print advertisements, clinic referrals and “word-of-mouth” have been the most
effective recruitment tool, together accounting for 2/3 of referrals to our study. These tools
are among the least expensive per participant yielded. Table 1 provides more detailed
information on recruitment tool efficacy. All potential participants, whether referred through
community events or their physician, are directed to a KU ADC recruitment coordinator for
a brief telephone screening.
All potential participants must have a study partner with whom they are in regular contact.
The study partner is asked to accompany the person to the initial examination and to serve as
a collateral source for evaluations. Although the study partner is not required to accompany
the participant to exercise sessions it is strongly encouraged for those who have limited
independence. The study provides a household membership to the Y to allow for this
participation.
Screening
Prior to enrollment and randomization, all participants undergo a standard evaluation in
multiple visits at the KU ADC. Prior studies have used an extended “run-in” period with
multiple visits to ensure commitment and availability.[66] The screening and baseline
testing process requires 3–4 visits over a 30-day period and takes approximately 9 hours to
complete. All visits occur at the University of Kansas Clinical and Translational Science
Unit (CTSU) or the Hoglund Brain Imaging Center, on the University of Kansas Medical
Center campus. Appointments are combined when scheduling allows
All participants receive a thorough clinical evaluation by a clinician through the KU ADC
which lasts about 1.5 hours. The clinical evaluation includes a Clinical Dementia Rating
(CDR),[79, 80] and semi-structured interviews with the participant and the study partner.
During the evaluation the clinician reviews the clinical history, past medical history, and
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medications. The clinician also performs a physical and neurological examination and
reviews inclusion and exclusion criteria (Table 2).
The clinical evaluation results are used to determine a presumptive clinical diagnosis which
is reviewed and finalized at a consensus diagnostic conference attended by KU ADC
clinicians and psychometricians using the NINDS-ADRDA criteria.[67] These methods
have a high diagnostic accuracy for AD of 93%.[68] At the consensus conference, the
examining clinician presents a brief clinical synopsis and CDR staging, followed by a
discussion of neuropsychological test results, and available clinical information from outside
evaluations (i.e., MRI, lab tests). Per recently updated criteria,[69] individuals classified
with MCI are also assigned an etiologic diagnosis (e.g. AD, cerebrovascular disease,
depression). Individuals classified as MCI who also demonstrate evidence of longitudinal
decline and characteristic objective cognitive findings are assigned an etiologic diagnosis of
probable AD.
If the individual meets inclusion criteria and has been assigned an etiologic diagnosis of AD,
screening continues with physical function testing and a graded maximal exercise test which
last approximately 2 hours. Testing is performed using a Modified Bruce protocol in the
presence of a medical monitor, exercise physiologist, nurse and spotter. Procedures for the
exercise test have been previously reported[70] and are reliable in this population.[71] All
participants are required to achieve a respiratory exchange ratio of at least 1.0 during the
exercise test to be randomized.[72] Those not meeting this threshold are asked to return for
an additional maximal exercise test. If it appears that orthopedic issues or participant
concerns are limiting performance, the retest can be performed on a total body recumbent
stepper.[73] If there are no orthopedic, cardiovascular or safety concerns raised during
testing (e.g. abnormal EKG, poor safety awareness) the participant is enrolled in the study.
Participants who do not meet inclusion and exclusion criteria or are otherwise identified as
inappropriate for the study are considered screen failures. For those enrolled, 2 additional
visits are required: a 15 minute fasting blood draw performed by a CTSU nurse and an MRI
visit that lasts approximately 2 hours performed by study staff and a certified imaging
technologist with experience in research protocols. Both visits are described in the Outcome
Measures section. Tests and measures acquired during the screening process are considered
baseline measures for enrollees. Although this extensive testing battery may be burdensome
to some participants successful completion of all baseline measures is an excellent indicator
of study completion and exercise adherence. In addition, our baseline screening procedures
provides excellent characterization of study participants, including a detailed assessment of
dementia and cognition, a limitation of previous studies.
Outcome Measures
Cognitive testing is performed by a trained psychometrician at a separate visit lasting
approximately 3 hours. (see Table 3 for tests, descriptions, and anticipated effect sizes) The
test battery includes standard measures of Verbal Memory, Executive Functioning (set
maintenance and switching), Visuospatial Construction, and Reasoning. Verbal Memory and
Executive Function factors serve as the primary outcomes measures for Aim 1. We use
Confirmatory Factor Analysis (CFA) on baseline cognitive scores to create factor score
weights which are then applied across the 3 times of measurement in this study. The Verbal
Memory and Executive Function factors (primary outcomes of Aim 1) are previously
validated in this neuropsychological battery.[74, 75] Thus we use the CFA as a weighting
schema to create more sensitive and specific summary scores (individual subtest loadings
are not tested) shown to be excellent discriminators of healthy and pathological aging in
both cross-sectional[74, 76, 77] and longitudinal [78] studies of Alzheimer’s disease.
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The study partner is asked to rate participants using the Quality of Life,[79] Cornell Scale
for Depression in Dementia,[80] Disability Assessment for Dementia,[81] Resource
Utilization in Dementia – Lite,[82] Alzheimer’s Disease Cooperative Study Activities of
Daily Living,[83] and Epworth Sleepiness [84] scales. The Disability Assessment for
Dementia and Cornell Scale for Depression in Dementia serve as primary outcome measures
for Aim 2.
Overnight fasting blood glucose is tested and a blood sample banked for Exploratory Aim 2.
The blood draw takes approximately 15 minutes and is often combined with another
appointment such as the MRI or cognitive testing. When appointments are combined with a
fasting lab draw, the participant is provided a voucher to eat after the fasting lab draw and
prior to their next appointment.
The physical function and exercise test visit consists of a battery of performance and
anthropometric measures. Waist and hip circumference, body weight and height and dual x-
ray absorptiometry (DXA) are performed with the participant in a standard hospital gown
with shoes removed. Then, the Physical Performance Test,[85] Senior Fitness Test,[86] and
the graded maximal treadmill test These measures will serve as indices of training effect.
Finally, all participants undergo magnetic resonance imaging (MRI) of the brain in a
Siemens 3.0 Tesla MRI scanner which takes no more than 1 hour. We obtain a high
resolution T1 weighted (MPRAGE) image (MP-RAGE; 1×1×1mm voxels; TR=2500,
TE=4.38, TI=1100, FOV 256X256 with 18% oversample, 1mm slice thickness, flip angle 8
degrees) for detailed anatomy with high gray-white matter contrast and a Fluid Attenuated
Inversion Recovery (FLAIR) sequence for improved imaging of the periventricular white
matter and discrimination of perivascular spaces from infarcts (1×1×4 mm voxels; flip angle
= 180 deg; TI = 2500, TR=10,000s, TE=81.0 ms). We use voxel based morphometry (VBM)
analysis of the MRI as our imaging outcome to explore exercise-related effects on brain
atrophy. VBM examines the whole brain and selected regions of interest in an unbiased way
with high sensitivity to identify small changes in brain structure over time. Data analysis
will be performed using the VBM8 toolbox (http://dbm.neuro.uni-jena.de), an extension of
the SPM8 algorithms (Wellcome Department of Cognitive Neurology, London, UK)
running under MATLAB 7.3 (The MathWorks, Natick, MA, USA) on Linux. Every scan is
checked for image artifacts and gross anatomical abnormalities. Subjects are excluded for
movement artifact or any inhomogeneity that distorts brain matter.
Randomization and Study Blinding
Participants are randomized equally to either aerobic or non-aerobic exercise. A block
randomization procedure is used, stratified by age (<75 years vs. >=75 years old) and gender
to ensure the groups are well-matched across these variables. The randomization sequences
were constructed prior to study start by the KU Department of Biostatistics. Randomization
is performed immediately upon successful completion of the exercise test.
The psychometrician, clinical evaluator, and staff involved in the exercise testing are
blinded to randomization assignment. Participants are asked at the beginning of each visit
not to discuss anything regarding their intervention with testing staff. However, maintaining
blinding can be a challenge with cognitively impaired participants. The PI remains un-
blinded to perform safety assessments, review laboratory data, and address safety concerns
or adverse events. Participants are not blinded to intervention arms. However, at the time of
consent, the phrases “aerobic exercise” and “non-aerobic activities” are used rather than
using “intervention” and “control”.
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Cognitive and physical function testing is generally performed by a single, trained rater from
a prepared script and study-specific instruction manual. In the rare instances that the primary
tester is unavailable, a second rater who has trained with the primary rater administers tests
from the same script and instruction manual. The rater who administered baseline measures,
tests the participant throughout the study to maintain consistency. Though cognitive tests are
not used in dementia staging process, tests and measures are discussed at the diagnostic
consensus conference attended by the evaluating clinicians, a clinical neuropsychologist
investigator and a physical therapist investigator and questions or concerns can be raised at
this time.
Exercise Intervention Justification
We suspect that walking at moderate intensity is the most common form of exercise for
older adults, is easily adopted and widely prescribed. Thus, it is likely easily adopted by this
population. The current study design attempts to isolate aerobic exercise in order to examine
its role in enhancing cognition. The intervention length of 26 weeks was chosen as
substantial physiological adaptations to exercise occur in the first 3 to 4 months of exercise
and major changes are unlikely beyond 6 months of training.[66] Considering the increased
logistical and participant burden of longer durations, we chose a 26- week intervention for
this study.
Exercise Intervention Implementation
All participants follow the same protocol with regard to warm up and cool down, duration of
exercise session, one-on-one trainer time as well as for heart rate monitoring during the
exercise session (Polar F4 or FT4, Polar Electro Inc., Lake Success, NY). The study
coordinator meets with each participant at the Y to review randomization and facilitate an
introduction to the assigned certified personal trainer (CPT) and facility. At that time
participants are provided an exercise log and a Polar heart rate monitor, which are kept at the
Y in a provided study box typically in the CPT’s locked office. The exercise log contains 26
sheets and includes a place to record AEs as well as a weekly goal for duration and intensity
(aerobic arm) or duration and activity (control group). All participants begin the intervention
with a weekly goal of 60 minutes in Week 1 and increase their weekly exercise duration
goals by approximately 21 minutes per week until they achieve the current public health
recommended target duration of 150 minutes per week. Participants are asked to accomplish
this target duration in 3–5 sessions so that sessions are no less than 30 minutes and no more
than 50 minutes per day. Total exercise duration, duration in the target zone, average heart
rate, peak heart rate, activity and a rating of perceived exertion (Borg 6–20) are gathered
during each exercise session. CPTs and study staff assist participants with Polar monitors,
how to keep their heart rate within a target zone and how to retrieve the session data from
the watch to record on the exercise log. Data are recorded at the end of every session. If the
participant does not become independent with retrieving data from the watch, the CPT is
instructed to do so every session for the participant.
Participants are directly supervised by the CPT during all exercise sessions for the first 6
weeks of exercise after which direct supervision occurs during at least one session a week.
We encourage each Y facility to have 2 or more CPTs trained and competent to lead both
arms of our study protocol. This is intended to provide increased convenience for the
participant while maintaining direct contact to enhance adherence. During supervised
sessions, CPTs check in with participants to assess AEs, review exercise logs and encourage
continued participation. The study coordinator and the CPT make a decision as to whether
the individual is ready to exercise independently. The decision is based on the ability to use
the heart rate monitor and gather information from the watch, safety and adherence to the
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exercise routine. If participants are unable or unwilling to use the treadmill, CPTs educate
them on the non-weight bearing modalities such as a recumbent stepper or stationary
bicycle.
The study pays for a household membership to the Y for the duration of the intervention as
well as the personal trainer fees. All exercise sessions are completed at the Y. The aerobic
arm utilizes Y treadmills and the non-aerobic arm utilizes Y equipment for the various
activities. The study provides the resistance bands in to standardize this activity. While the
CPT is training a study participant, he/she is considered a research assistant on the project
therefore reports to the study coordinator with regard to study-related activities. The study
coordinator meets with each participant at the Y to review randomization and facilitate an
introduction to the assigned certified personal trainer (CPT) and facility.
Aerobic Exercise Arm
Target heart rate (THR) zones are calculated for each participant randomized to the aerobic
exercise arm. Both exercise duration and THR zone are manipulated to gradually introduce
exercise and maximize aerobic training benefit. Participants are instructed to gradually
increase speed and incline on the treadmill over approximately 5-minutes to warm-up and
gradually reach their THR. The first 4 weeks of exercise, the THR zone is 40 – 55% of heart
rate reserve (HRR) as calculated by the Karvonen formula from resting and peak heart rate
gathered during the exercise test. The THR zone for Weeks 5–18 is 50 – 65 % of HRR. The
THR for the final 8 weeks is 60 – 75% of HRR. Participants are instructed to gradually
decrease speed and incline on the treadmill over approximately 5-minutes to cool down.
Participants who cannot tolerate treadmill are instructed on use of an alternative aerobic
modality.
Non-aerobic Activities Arm
Stretching and toning exercises such as those in our non-aerobic activities arm are
commonly used as a control condition in research studies of aerobic exercise.[87–89]
Participants in the nonaerobic activities group are given a THR of <100bpm. A pictorial
manual of activities is provided to each CPT and the participants. The activities include axial
and appendicular stretching and toning exercises, seated exercises on a large diameter
exercise ball and modified versions of Tai Chi and yoga. All non-aerobic exercise session
begin with a slow-paced walk on the track for approximately 5 minutes to provide a warm-
up for the participant. CPTs are provided with a schedule of specific exercises and verbal
instructions to participants. CPTs are encouraged to be creative with these activities as long
as the variations fall within the intent of the exercises in the manual, are not progressive and
do not cause heart rate to surpass the THR. All non-aerobic exercise sessions end with
stretching exercises to provide a cool-down for the participant.
Community Implementation
Successful delivery of an exercise program to a large community such as the Kansas City
metropolitan area requires several easily accessible sites. The KU ADC established a
partnership with the Y because of its significant infrastructure (18 locations), brand
recognition within the aging community, and long-time association with physical activity
and health promotion. The synergistic relationship between the KU ADC and the Y is at the
core of the study. The key on which the partnership was built was agreement that the study
results will inform methods in which community organizations such as the Y can serve older
adults with memory loss. Importantly, the ADEPT research objectives match the mission
and vision of the Y to serve the community through supporting healthy living. The KU ADC
expands the Y’s capacity to serve older adults and broadens their scope of activities beyond
traditional membership-based exercise programming. Working with the KU ADC enhances
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the Y’s ability to provide healthy living opportunities to the community in innovative ways.
In return, the KU ADC receives the dedication of and access to facilities and CPTs. The
network of 18 facilities expands the reach of the study and eases participant time and travel
burden, and in many cases introduces individuals to a neighborhood resource they have
never used.
As with any partnership between institutions with different policies there are challenges to
overcome. First, training for research-level human subjects’ protections is not standard for
the Y and second, Y staff members bring various levels of familiarity with clinical trial
methods as well as with aging and memory loss. Unique mechanisms for trainer time and
membership reimbursement have also been developed to accommodate the study. The study
coordinator works with the Business Director of Corporate Billing at the Y Association
office to direct bill for each study membership and CPT hours spent training our
participants. The study coordinator communicates the required information for membership
set-up and the Business Director sets up the membership remotely in the appropriate Y’s
database ready for the participant’s arrival. The CPTs track their contact time with
participants on a provided ADEPT time sheet and submit the time sheet to the Business
Director to invoice us for those hours. The study coordinator verifies the trainer hours with
the exercise logs.
To standardize implementation of the intervention protocols and facilitate training of CPTs,
a study training manual was developed by KU ADC staff. All CPTs who work with study
participants receive the study training manual as well as extensive in-person training by the
study coordinator. The study training manual contains detailed instruction on the study
protocol, maintaining adherence to the study protocol, reporting AEs, recording study data,
the importance of human subjects’ protection as well as instruction on working with people
with dementia. The importance of the trainer to follow the protocol and to be the “eyes-and-
ears” of the study is heavily emphasized. Federal and institutionally required human
subjects’ protection and HIPAA compliance courses are completed by CPTs through online
training modules hosted by the University of Kansas Medical Center.
Adverse Events
The study coordinator assesses AEs within 3 days of initiating exercise intervention and the
CPTs are asked to assess for AEs or medication changes at the beginning of each visit.
When the CPT is not supervising the participant, participants are instructed to note the AE
on their exercise log as well as report the AE to the study coordinator by phone. CPTs are
provided a standard form modified from previous community-based studies [90] to assist
with identifying and documenting AEs. These documents are faxed to the KU ADC, at
which time a follow-up call is made to the participant to obtain additional information
regarding the AE. All AEs and medication changes from baseline are logged and entered in
to the study database. Participants and their study partner are contacted by phone by the
study coordinator for formal review of medication changes, medical history, and AEs at
weeks 3, 6, 9, 16, 19, and 22. The seriousness of the AE is determined using the National
Cancer Institute Common Terminology Criteria for Adverse Events v3.0. If the participant,
study partner, or CPT reports AEs or complaints to the study coordinator, the AE is
evaluated by the unblinded investigator and a course of action is determined. CPTs are
instructed to follow the Y’s emergency response protocol in the event of such emergency
and to follow up by contacting the study coordinator.
Retention and Adherence
The periodic telephone assessments by the study coordinator complement the CPTs routine
daily assessment of AEs as well as enhance communication between the study team and the
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participants. Additionally, the calls encourage compliance with the intervention. To further
enhance compliance, the study coordinator visits the facilities bi-weekly when study
participants are exercising. This visit provides an opportunity to ensure protocol adherence
by reviewing the logs for compliance, providing feedback and additional training on the
protocol and stressing the importance of complying with the study protocol to both CPTs
and participants. Copies of the exercise logs are collected for staff review and data entry. If
the study coordinator does not make contact with a study participant during the visit, a
message is written on the current week’s exercise log. These messages are meant to inform
the participant the study coordinator came to visit; to provide words of encouragement; and
relay any relevant notes about the participant’s progress.
Sample Size and Power Calculation
Because this is a pilot study, the sample size was determined to provide estimates of
intervention effect sizes on outcome measures. However, the moderate sample size is
sufficient for preliminary hypothesis testing. We are recruiting 80 patients with the
expectation that 60 individuals will eventually complete the study, a sample size sufficient
to plan a more definitive future study.
We also estimated the power of this study based on prior reports (see Table 3). We reviewed
the exercise intervention literature in geriatric populations that used similar primary outcome
measures to gain effect size estimates. Estimates obtained using AD patient populations and
longitudinal designs were used preferentially. We found effect sizes for Logical Memory
[91] (7 studies; effect size ranges from 0.03 to 1.44 and sample size ranges from 8 to 87).
Figure 1 shows the power of our study at testing different effect sizes reported in the
literature using one-sided two sample t-test at alpha level of 0.05 when the attrition rate is
20% or 0. The power of the present study is between 0.64 to 0.72 if the effect size is 0.5.
Cognitive and functional test data (primary outcome measures) are collected at baseline,
Week 13 and Week 26 to enhance power as these are less directly associated with exercise
compared to peak oxygen consumption or the Physical Performance Test for example.
Currently, the study has excellent retention with only 2% drop out and approximately half of
study participants enrolled.
Analysis Plan
Using latent variable analysis we will aggregate common (true) score instrument items to
generate the two co-primary outcomes for Aim 1: Verbal Memory and Executive Function.
Latent variable analysis is a widely used statistical method to aggregate common variance
across items and attenuate error. Latent variable analysis allows extraction of what is
domain specific among several contributing items/tasks. Because this method pools common
score variance and minimizes error variance (idiosyncratic to the item/task), resultant
summary scores provide purer measurement of target domains than do individual tasks [92]
Resultant summary scores yield more reliable, sensitive, and specific estimates of ability
than do traditional analyses of raw scores or scaled score composites because they are purer
indices of ability. Hypothesized causal relationships among these summary variables can be
empirically tested using structural equation modeling.
We will use a linear mixed model to analyze each primary outcome measure. We will
estimate the effect of intervention versus control as the interaction between group and time
and also estimate the effect size of intervention using liner contrasts. We will test the linear
trend difference between the exercise group and the control group. A linear mixed model is
expected to be slightly more powerful than a t-test because of the repeated measures and the
capability of the model at accommodating missing data. As this is a pilot study with small
Vidoni et al. Page 10













sample size, all the analysis will be conducted individually without adjustment for multiple
outcomes.
Secondary measures will be evaluated in a similar manner as our primary outcomes.
Secondary outcomes will be clearly indicated as such in resulting manuscripts.
Because of the attention paid to uniformly training CPTs we expect that training site have
minimum impact on the outcomes, and anticipate that 10 of the 18 local Y sites for training
and each site may provide 1–3 CPTs. With 60 patients in total, patients allocated to sites and
CPTs will be too sparse for complicated hierarchical regression models. We will not take the
cluster effects of Y site and trainer into analysis. ITT may be examined and estimated for
future studies. Every reasonable effort is made to maintain rater consistency from baseline to
follow-up.
VBM–indexed brain atrophy between intervention groups will be our exploratory
neuroimaging outcome measure. The final tissue maps of gray matter, white matter and
cerebrospinal fluid will be modulated in order to analyze relative volume differences
between exercise groups and over time. This approach has been used effectively in exercise
studies of similar duration in nondemented older adults[93].
We will determine circulating levels of metabolic and inflammatory biomarker levels
(Insulin, IGF-1, IL- 6, and TNFa). A blood draw will be performed following an overnight
(~12h) fast. Serum will be collected and assayed using commercially available ELISA
assays (ALPCO Diagnostics).
Discussion
The purpose of this paper is to report our project protocol to guide future studies. While this
study is too small to draw definitive conclusions, it may impact public health policy by
encouraging research into the effects of aerobic exercise on AD. It may also stimulate
development of community-deliverable aerobic exercise programs. The long-term objective
of this research line is to assess the degree to which aerobic exercise is associated with
healthy brain aging and reduced AD progression. The idea that regular exercise and physical
activity has positive benefits for general health, reduces morbidity and mortality, and is an
essential component of managing chronic disease is beyond discredit. However, it remains
uncertain how exercise may benefit brain health and cognitive function in AD, now one of
our most costly and pervasive age-related diseases.
ADEPT is designed to address previous study limitations that confound interpretation of
aerobic effects on brain health and AD progression. Block randomization is performed to
ensure balance of age and sex across treatment arms. Our control arm (stretching and toning)
provides equal social contact and physical engagement without aerobic activity for
participants. An additional improvement over prior studies is our careful characterization of
potential participants and inclusion of only those in the earliest stages of AD. By using a
standard evaluation, diagnosis and cognitive work up we can be confident that our cohort
reflects a group in the earliest stages of AD rather than the potentially mixed cohort of
previous studies.[41–51]
The partnership between the KU ADC and the Y provides additional advantages for
conducting research. This arrangement provides evidence regarding translation of findings
to a community deployable program. Additionally, conveniently located community
facilities reduce participant and study partner burden. Y facilities employ CPTs and serve as
a focal point for community engagement and participation. Older individuals tend to be
familiar with the brand and in our experience, have been so positive about attending sessions
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at the Y they have purchased a membership after study participation. Key to a successful
study is engagement of both the participant and study partner.[94] In ADEPT, as with
previous studies [40] both the participant with AD and the study partner can engage in the
exercise. This dyadic inclusion and focus may further improve study engagement and
retention.
Limitations
As with any study, there are limitations inherent in the design. The community-based
intervention increases the possibility that differences between CPTs will influence
outcomes. To address this the CPTs undergo extensive protocol training and we maintain a
“hotline” phone number that is staffed at all times for trainer or participant questions.
Maintaining open lines of communication with study staff allows CPTs to ask questions
about the study protocol and report AEs. A second limitation of this study is its scope. The
study is not large enough for definitive evaluation of aerobic exercise effects on AD. That
being said, partnership with the Y offers a national infrastructure for deploying a more
definitive future trial powered by the common and responsive outcome measures of
cognition and function chosen for this study.
Conclusion
We have described a small pilot trial of aerobic versus non-aerobic exercise for those in the
earliest stages of AD. The foundation of this study is the partnership of a public academic
medical center and private enterprise to deliver the intervention in a familiar environment
using readily available community resources. Scientific rigor is maintained while
minimizing participant burden. The results will inform the development of a more definitive
multi-site clinical trial that could be delivered in almost any city with a research university
and community fitness resources.
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shows the power of our study at testing different effect sizes using one-sided two sample t-
test at alpha level of .05 when the attrition rate is 20% or 0. The observed effect sizes of
Logic Memory from the 7 studies in the literature are marked in the plot. Each number on
the plot denotes the sample size of the corresponding study. From this plot, a reasonable
estimate of the effect size of logic memory is about .45 and the power is within .56 to .64
depending on the attrition rate. The power of the study is from .64 to .72 if the effect size is .
5.
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Table 1
ADEPT inclusion and exclusion criteria.
Inclusion Criteria Exclusion Criteria:
• Informed consent
• Age 55 years or older
• Underactive or sedentary based on the
Telephone
• Assessment of Physical Activity.[95]
• Community dwelling with a caregiver willing
to accompany the participant to visits to the
screening evaluation. The caregiver must visit
with the subject more than five times a week.
• CDR 0.5 or 1
• Adequate visual and auditory abilities to
perform all aspects of the cognitive and
functional assessments
• Stable doses of medications for at least 30 days
prior to screening.
• Likely to participate in all scheduled
evaluations and complete the exercise program
over 26 weeks
• Current clinically significant major psychiatric disorder (e.g., Major
Depressive Disorder) according to DSM-IV criteria or Geriatric
Depression score of 5 or greater.
• Significant psychiatric symptoms (e.g., hallucinations) that could
impair the completion of the study
• Current clinically-significant systemic illness likely to result in
deterioration of the patient’s condition or affect the patient’s safety
during the study
• History of clinically-evident stroke
• Clinically-significant infection within the last 30 days
• Myocardial infarction or symptoms of coronary artery disease (e.g.,
angina) in the last two years.
• Uncontrolled hypertension within the last 6 months
• History of cancer within the last 5 years (except non-metastatic basal
or squamous cell carcinoma)
• History of drug or alcohol abuse as defined by DSM-IV criteria
within the last 2 years
• Insulin-dependent diabetes mellitus
• Significant pain or musculoskeletal disorder that would prohibit
participation in an exercise program
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Table 2
Recruitment Cost per Referral
Medium Cost Calls Generated Cost per Call
Direct to Home Advertisement Mailing (Valpak) $3480 96 $36.25
Print Advertisement $1599 221 $7.24
Direct Mail Campaigns to Existing Research Databases $629 78 $8.07
Brochures in Physician Clinics and Y facilities $308 15 $20.51
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Table 3
Cognitive Test Battery and Reported Effect Sizes of Exercise
Description Effect Size Range
Verbal Memory
Selective Reminding Test [96] Picture list learning with structured category-cuedreminding and uncued recall. 0.16 to 0.59[97, 98]
Logical Memory†* [99] Prose recall of short narrative passages. 0.02 to 1.44 [100–106]
Boston Naming Test* [107] Naming of figural line drawings.
Executive Function
Stroop Color-Word Test Word reading and color naming requiring setmaintenance and inhibition of irrelevant information.
0.09 to 0.40 [97, 98, 102, 108–
110]
D-KEFS Card Sort Card-sort requiring concept formation, set maintenance,and switching. 0.08 to 1.61 [98, 111, 112]
Category Fluency* [113]
Spoken wordlist generation to a target category (Animals
or Vegetables).
0.17 to 1.16 [97, 98, 108, 112,
114, 115]
Letter-Number Sequencing
Immediate memory for numbers and letter, requiring
information to be maintained and manipulated in mind
by self-ordered recall of like sets.
NA
Digit Span (Forward & Backward)* [99]
Immediate memory for numbers, requiring information
to be maintained and manipulated in mind.
0.05 to 3.50 [97, 100, 102–104,
106, 108, 110, 116–123]
Visuospatial Construction
Digit Symbol * [124]
Test of psychomotor speed involving sustained attention
and transcription of digit-symbol pairs.
0.11 to 0.77 [98, 101–104, 106,
108–110, 112, 114, 115, 117, 118,
125]
Trail Making Test * (Parts A and B) [126]
Line drawing between alternating numbers and letters,
requiring visual search, attention, and mental flexibility.
0.06 to 0.82 [102, 106, 108, 109,
112, 114–117, 121]
Block Design[124] Visuospatial construction using blocks to match targetmodels NA
Reasoning




Inference making based on principles derived from
informative models containing letters, words, and
numbers.
NA
Matrix Reasoning [124] Inference making based on principles derived frominformative models containing colored patterns. 0.21 to 1.18 [105, 111, 112, 121]
Picture Arrangement [124] Card-sort requiring temporal sequencing and socialreasoning. 0.19 [123]
Functional Disability
Disability Assessment for Dementia [128] Scale of need for assistance on basic and instrumentalactivities of daily living. 0.4–0.8 [129]
Cornell Scale for Depression in Dementia
[130]
Scale combining participant and informant ratings of
mood and behavior. 0.15 [131]
Quality of Life [133] 13-item measure given to participant and study partnerregarding perceived quality of life of participant. NA
Alzheimer’s Disease Cooperative Study -
Activities of Daily Living [83]
Measure given to study partner regarding independence
in basic and instrumental activities of daily living. NA
Epworth Sleepiness Scale [84] Rating of likelihood of falling asleep during activities,scored 0–24 0.47 [94]
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Description Effect Size Range
Resource Utilization in Dementia – Lite[82,
132]
Survey of heath care resource use and time for providing
participant care completed by study partner. NA
NA – Not available




ACTIVE Battery Subtest (or close analogue)
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